This includes a potential immunomodulatory strategy to target NLRP3, Foxp3 and IRF4/8 in immune cells to achieve anti-inflammatory effects in IHD, although little data on concrete approaches is available yet. This evidence concerns the gene FOXP3 and myocardial ischemia.